Cyclin-dependent kinase 5 regulates proliferation, migration, tyrosinase activity, and melanin production in B16-F10 melanoma cells via the essential regulator p-CREB
- 86 Downloads
Melanoma is an aggressive cancer with increasing incidence and a growing lifetime risk that arises from normal melanocytes or their precursors. A thorough understanding of the molecular mechanism of melanomagenesis and melanoma biology is essential for the diagnosis, prognostication, and therapy of melanoma. Cyclin-dependent protein kinase 5 (Cdk5) is one of the proteins highly expressed in B16-F10 melanoma cells that controls melanoma cell motility, invasiveness, and metastatic spread and might be a promising novel therapeutic target. The effect of Cdk5 on proliferation and migration, which are important for carcinogenesis, has not been reported. In the current study, we found that siRNA-mediated knockdown of Cdk5 in B16-F10 melanoma cells inhibited melanoma cell proliferation through downregulation of the CaMK4-p-CREB pathway, inhibited migration through downregulation of p-CREB, integrin beta 1, and integrin beta 5, and also inhibited tyrosinase activity and melanin production through p-CREB-MITF regulation. The results indicate that Cdk5 controls melanoma development, with an essential regulatory role for p-CREB.
KeywordsMelanoma Proliferation Migration Cdk5 Phosphorated CREB (p-CREB)
This work was supported by a Special Fund for the Young Sanjin Scholars Distinguished Professor (Ruiwen Fan) and Research Project Supported by Shanxi Scholarship Council of China (2017-072).
Compliance with ethical standards
Conflicts of interest
The authors declare that they have no conflict of interests.
- Bertolotto C, Buscà R, Abbe P, Bille K, Aberdam E, Ortonne JP, Ballotti R (1998) Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol 18:694–702CrossRefGoogle Scholar
- Bisht S, Nolting J, Schütte U, Haarmann J, Jain P, Shah D, Brossart P, Flaherty P, Feldmann G (2015) Cyclin-dependent kinase 5 (cdk5) controls melanoma cell motility, invasiveness, and metastatic spread-identification of a promising novel therapeutic target1. Transl Oncol 8(4):295–307CrossRefGoogle Scholar
- Böhm M, Moellmann G, Cheng E, Alvarezfranco M, Wagner S, Sassonecorsi P, Halaban R (1995) Identification of p90rsk as the probable creb-ser133 kinase in human melanocytes. Cell Growth Differ 6(3):291–302Google Scholar
- Chuong CM, Nickoloff BJ, Elias PM, Goldsmith LA, Macher E, Maderson PA, Sundberg JP, Tagami H, Plonka PM, Thestrup-Pedersen K, Bernard BA, Schröder JM, Dotto P, Chang CH, Williams ML, Feingold KR, King LE, Kligman AM, Rees JL, Christophers E (2002) Contoversies in experimental dermatology. Exp Dermatol 11(2):159–187CrossRefGoogle Scholar
- Liu X, Zhang P, Ji K, et al (2017) Cyclin-dependent kinase 5 regulates MAPK/ERK signaling in the skin of mice. Acta Histochemica 120(1):S0065128117302970Google Scholar
- Tobin DJ (2005) Biochemistry of human skin — our brain on the outside. Cheminform 35(1):52–67Google Scholar
- Winkler J, Roessler S, Sticht C, Diguilio AL, Drucker E, Holzer K, Eiteneuer E, Herpel E, Breuhahn K, Gretz N, Schirmacher P, Ori A, Singer S (2016) Cellular apoptosis susceptibility (cas) is linked to integrin β1 and required for tumor cell migration and invasion in hepatocellular carcinoma (hcc). Oncotarget 7(16):22883–22892CrossRefGoogle Scholar